The North America Infertility Drugs Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Medicaid's reimbursement of maternity and family planning services stands in contrast with its complete absence of coverage for fertility treatments. Medicaid supports the bulk of publicly funded family planning services as well as roughly half of the births in the U.S. As a consequence, even though numerous contraceptive and low-income services are often offered throughout pregnancy, there is limited access to help for low-income pregnancies. Only one state, New York, permits Medicaid to pay for fertility services in the United States as of January 2020. These are the main obstacles to market expansion.
Governments have launched a number of programs to help those who are struggling with infertility by offering insurance coverage for therapy. The Ministry of Health, Labor, and Welfare (MHLW), for instance, announced the payment under the national health insurance program in March 2022. By reducing the cost by 70% and increasing the number of prescriptions for medications, this program improves patients' access to care.
It is also anticipated that the availability of a broad range of medications for the treatment of infertility issues would benefit the industry. For instance, some of the fertility drugs on the market include Crinone (progesterone gel), Pregnyl (chorionic gonadotropin), Ovidrel (choriogonadotropin alfa), Menopur (Gonal-F), Follistim A (follitropin beta), Ganirelix Acetate Injection, Cetrotide (cetrorelix acetate), Clomid (clomiphene citrate), Bravelle (urofollitropin), and First-Progesterone.
One of the main factors influencing the development of the infertility medications market in the U.S. is the high concentration of market participants or manufacturer's presence, acquisitions, and partnerships among significant companies and an increase in the number of infertility and PCOS patients in the nation. These occurrences thus show that the market in the United States is expanding significantly. As a result of the aforementioned variables, the North American region expects the studied market to increase.
The US market dominated the North America Infertility Drugs Market by Country in 2021; thereby, achieving a market value of $1,312.5 million by 2028. The Canada market is experiencing a CAGR of 8% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 7% during (2022 - 2028).
Based on End User, the market is segmented into Women and Men. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy. Based on Drug Class, the market is segmented into Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Infertility Drugs Market is Predict to reach $4.8 Billion by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Ferring Holdings SA, Organon & Co. and Mankind Pharma Ltd.
Scope of the Study
Market Segments Covered in the Report:
By End User
By Distribution Channel
- Hospital Pharmacy
- Specialty & Retail Pharmacy
- Online Pharmacy
By Drug Class
- Gonadotropins
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
- Dopamine Agonists
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Bayer AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sanofi S.A.
- Ferring Holdings SA
- Organon & Co.
- Mankind Pharma Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Infertility Drugs Market, by End User
1.4.2 North America Infertility Drugs Market, by Distribution Channel
1.4.3 North America Infertility Drugs Market, by Drug Class
1.4.4 North America Infertility Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Infertility Drugs Market by End-user
3.1 North America Women Market by Country
3.2 North America Men Market by Country
Chapter 4. North America Infertility Drugs Market by Distribution Channel
4.1 North America Hospital Pharmacy Market by Country
4.2 North America Specialty & Retail Pharmacy Market by Country
4.3 North America Online Pharmacy Market by Country
Chapter 5. North America Infertility Drugs Market by Drug Class
5.1 North America Gonadotropins Market by Country
5.2 North America Aromatase Inhibitors Market by Country
5.3 North America Selective Estrogen Receptor Modulators (SERMs) Market by Country
5.4 North America Dopamine Agonists Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Infertility Drugs Market by Country
6.1 US Infertility Drugs Market
6.1.1 US Infertility Drugs Market by End-user
6.1.2 US Infertility Drugs Market by Distribution Channel
6.1.3 US Infertility Drugs Market by Drug Class
6.2 Canada Infertility Drugs Market
6.2.1 Canada Infertility Drugs Market by End-user
6.2.2 Canada Infertility Drugs Market by Distribution Channel
6.2.3 Canada Infertility Drugs Market by Drug Class
6.3 Mexico Infertility Drugs Market
6.3.1 Mexico Infertility Drugs Market by End-user
6.3.2 Mexico Infertility Drugs Market by Distribution Channel
6.3.3 Mexico Infertility Drugs Market by Drug Class
6.4 Rest of North America Infertility Drugs Market
6.4.1 Rest of North America Infertility Drugs Market by End-user
6.4.2 Rest of North America Infertility Drugs Market by Distribution Channel
6.4.3 Rest of North America Infertility Drugs Market by Drug Class
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.3 Novartis AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Merck & Co., Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Ferring Holdings SA
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research and Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Organon & Co.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Mankind Pharma Ltd.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
TABLE 1 North America Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 2 North America Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 3 North America Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 4 North America Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 5 North America Women Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Women Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Men Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Men Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 10 North America Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 11 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Specialty & Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Specialty & Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 18 North America Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 19 North America Gonadotropins Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Gonadotropins Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Aromatase Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Aromatase Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Dopamine Agonists Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Dopamine Agonists Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Infertility Drugs Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Infertility Drugs Market by Country, 2022 - 2028, USD Million
TABLE 31 US Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 32 US Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 33 US Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 34 US Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 35 US Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 US Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 US Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 38 US Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 39 Canada Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 40 Canada Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 41 Canada Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 42 Canada Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 43 Canada Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 Canada Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 Canada Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 46 Canada Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 47 Mexico Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 48 Mexico Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 49 Mexico Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 50 Mexico Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 51 Mexico Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 Mexico Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 Mexico Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 54 Mexico Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 55 Rest of North America Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 56 Rest of North America Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 57 Rest of North America Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 58 Rest of North America Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 59 Rest of North America Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Rest of North America Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Rest of North America Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 62 Rest of North America Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 63 Key Information – Abbott Laboratories
TABLE 64 Key Information – Bayer AG
TABLE 65 Key Information – Novartis AG
TABLE 66 KEY INFORMATION - Merck & Co., Inc.
TABLE 67 Key Information – Pfizer, Inc.
TABLE 68 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 69 Key Information – Sanofi S.A.
TABLE 70 key information – Ferring Holdings SA
TABLE 71 Key Information – Organon & co.
TABLE 72 Key Information – Mankind Pharma Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories